The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) has become a one of the most important causes of nosocomial infections, and use of vancomycin for the treatment of MRSA infection has increased. Unfortunately, vancomycin-resistant enterococcus have been reported, as well as vancomycin-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ji-Hee, Lee, Ju-Hyung, Moon, Mi-Kyoung, Kim, Ju-Sin, Won, Kyoung-Suk, Lee, Chang-Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780940/
https://www.ncbi.nlm.nih.gov/pubmed/24265951
http://dx.doi.org/10.3947/ic.2013.45.1.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780940/
https://www.ncbi.nlm.nih.gov/pubmed/24265951
http://dx.doi.org/10.3947/ic.2013.45.1.62

Ejemplares similares